Financing type:  brokered private placement

Gross proceeds:  $3.75-million

Offering:  37.5 million listed shares with 18.75 million warrants attached

Offering price:  10 cents per listed share

Warrant exercise terms:  12 cents per listed share for a two-year period, subject to an acceleration right

Commissions in securities:  2,031,000 agents' warrants

Commission terms:  Each non-transferable warrant is exercisable to acquire one unit at 10 cents for a two-year period. Each unit consists of one common share in the company and one-half of one common share purchase warrant, with each warrant entitling the holder to acquire one common share of the company at a price of 12 cents per share.

Disclosure:  Refer to the company's news releases dated Oct. 9, 2025, Nov. 5, 2025, and Dec. 18, 2025.